Scott Braithwaite, MD, MSc
NYU Langone Health - Tenured Professor of Medicine
NYU Langone Health - Director, Division of Comparative Effectiveness and Decision Science
MD, Medicine, SUNY at Stony Brook School of Medicine
MSc, Clinical Research, University of Pittsburgh
BS, Physics, Massachusetts Institute of Technology
Research Interests
Cost-effectiveness, Decision science
R. Scott Braithwaite is a Tenured Professor, Chief of the Section on Value Effectiveness (SOLVE) and Director of the Division of Comparative Effectiveness at New York University School of Medicine-Department of Population Health.  Dr. Braithwaite earned his MD from the State University of New York at Stonybrook and his MSc in Clinical Research from the University of Pittsburgh. Dr. Braithwaite also completed a fellowship in Clinical Decision Making at Tufts University and is a recipient of a prestigious Robert Wood Johnson Foundation Faculty Scholar award. He is an accomplished investigator in the field of decision science, quality and cost-effectiveness with an outstanding record of funding from the NIH and other extramural sources. As chief of SOLVE, he is dedicated to advancing a program of rigorous, policy-relevant research to optimize quality and value in healthcare, incorporating methods of decision science, comparative effectiveness and cost effectiveness. In addition to his focus on improving care for chronic illness domestically, he also continues his important international work on HIV treatment strategies in developing countries.
Principal Investigator, 4/6 COMPAAAS U01: Operations Research Study. Active
Principal Investigator, Could Long-Acting Medications Facilitate “Ending AIDS by 2030” in Southern Africa? An Allocative Efficiency Analysis. Active
Principal Investigator, From 90-90-90 to 95-95-95 and Beyond: Optimizing and Targeting Combination HIV Prevention for Zimbabwe and Kwazulu Natal. Active
Principal Investigator, Reducing Morbidity and Mortality from Overdose, HIV, and Hepatitis C in Opioid-Using Persons. Active
Principal Investigator, Should Screening and Treatment Strategies for Unhealthy Alcohol Misuse in HIV-infected Persons Vary with Smoking, Depression and Substance Abuse?. Active
Principal Investigator, Benefits and Harms of Lung Cancer Screening in HIV Infection. Completed
Principal Investigator, Implementation Science to Optimize HIV Prevention in East Africa PEPFAR Programs. Completed
Principal Investigator, Mentored Career Development in Comparative Effectiveness Research. Completed
Principal Investigator, Operations Research Collaboration for Alcohol Abuse and AIDS: ORCAAA. Completed


Stevens ER, Mazumdar M, Caniglia EC, Khan MR, Young KE, Edelman EJ, Gordon AJ, Fiellin DA, Maisto SA, Chichetto NE, Crystal S, Gaither JR, Justice AC, Braithwaite RS (2020).
Insights provided by depression screening regarding pain, anxiety, and substance use in a veteran population
Journal of Primary Care and Community Health, 11, 2150132720949123. doi: 10.1177/2150132720949123. PMCID: PMC7418233.

Stevens ER, Nucifora KA, Hagan H, Jordan AE, Uyei J, Khan B, Dombrowski K, Des Jarlais D, Braithwaite RS (2020).
Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population
Clinical Infectious Diseases, 70 (12), 2652-2662. doi: 10.1093/cid/ciz726. PMCID: PMC7286369.

Bershteyn A, Sharma M, Akullian AN, Peebles K, Sarkar S, Braithwaite RS, Mudimu E (2020).
Impact along the HIV pre-exposure prophylaxis “cascade of prevention” in western Kenya: A mathematical modelling study
Journal of the International AIDS Society, 23 (Suppl 3), e25527. doi: 10.1002/jia2.25527. PMCID: PMC7325506.

Khan MR, Young KE, Caniglia EC, Fiellin DA, Maisto SA, Marshall BDL, Edelman EJ, Gaither JR, Chichetto NE, Tate J, Bryant KJ, Severe M, Stevens ER, Justice A, Braithwaite SR (2020).
Association of alcohol screening scores with adverse mental health conditions and substance use among US adults
JAMA Network Open, 3 (3), e200895. doi: 10.1001/jamanetworkopen.2020.0895. PMCID: PMC7068229.

Uyei J, Taddei TH, Kaplan DE, Chapko M, Stevens ER, Braithwaite RS (2019).
Setting ambitious targets for surveillance and treatment rates among patients with hepatitis C related cirrhosis impacts the cost-effectiveness of hepatocellular cancer surveillance and substantially increases life expectancy: A modeling study
PLoS One, 14 (8), e0221614. doi: 10.1371/journal.pone.0221614. PMCID: PMC6709904.

Dr. Braithwaite's ResearchGate Profile